The history of Sildenafil presents a challenging picture for shareholders. While the initial introduction generated substantial profits, the expiration of its intellectual property protection opened the floodgates to https://thebookmarknight.com/story21608840/sildenafil-and-big-pharma-a-risky-opportunity